News
Keeping you up to date with the clinical research sector innovations and news
Industry news
- Gefurulimab Demonstrates Statistically Significant and Clinically Meaningful Improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) at Week 26 with Clinically Meaningful Improvement Seen as Early as Week One in Adults with gMG in PREVAIL Phase III Trial
- Novartis Ianalumab First Drug to Reduce Disease Activity and Patient Burden in Sjögren’s Disease Phase III Trials
- Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
- Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Fast Track Designation by FDA for the Treatment of PROC
- Heidelberg Pharma Receives Fast Track Designation from the US FDA for its Lead ADC Candidate HDP-101 for the Treatment of Multiple Myeloma
- Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
- Wearable technology to be offered to thousands with type 1 diabetes in UK
- NHS expands home-testing kits to detect bowel cancer earlier
- Novo Nordisk Foundation establishes new vaccine initiative worth $260m
- Key Parkinson’s protein could offer new potential targets for treatment
- BioMed X and Ono Pharmaceutical enter joint cancer research project
- Heart vests to identify those at high risk of sudden cardiac death
- Digital health collaboration to trial AI-powered X-rays for lung cancer detection
- Cognitive decline in early Alzheimer’s could stem from serotonin loss
- New filtering system to combat spread of infections in hospitals
- AstriVax awarded €3m to develop therapeutic vaccine for hepatitis B
- Sano Genetics launches ‘Light the Way’ programme for MND
- PharmaKure and UiTM enter research partnership for Alzheimer’s disease
- Study confirms safety of new flow-diverting stent to treat brain aneurysms
- ACSR to use digitised pathology for HIV-associated malignancies
- New study finds heathy cells ‘push’ cancer cells to resist treatment
- Babies born early have an increased risk of developmental disorders
- UKHSA urges individuals from ethnic minority groups to get vaccinated
- NHS rolls out online GP registration to over 2,000 practices
- Cambridge researchers redesign future mRNA therapeutics
- BioMed X launches call for applications in autoimmune disease research
Tailored Clinical Research Solutions
Holborn Gate,
330 High Holborn
London
WC1V 7QH
